Z-0659-2021Class II

IceFORCE" 2.1 CX L 90 Cryoablation Needle

Name: Z-0659-2021 IceFORCE" 2.1 CX L 90 Cryoablation Needle
Creator: Boston Scientific Corporation
Published: 2020-11-18
License: https://open.fda.gov/license/

Boston Scientific Corporation / initiated 2020-11-18 / Completed

FDA source

Boston Scientific Corporation began a recall of IceFORCE" 2.1 CX L 90 Cryoablation Needle on 2020-11-18. FDA classified it as Class II and gives the reason as "Complaint trend regarding needle shaft gas leaks". As of 2026-09-10, the recall status on record is Completed.

Recall record

Recall number: Z-0659-2021
Classification: Class II
Status: Completed
Initiated: 2020-11-18
Posted: 2020-12-22
Recalling firm: Boston Scientific Corporation
Product: IceFORCE" 2.1 CX L 90 Cryoablation Needle
Product code: GEI Electrosurgical, Cutting & Coagulation & Accessories
Reason for recall: Complaint trend regarding needle shaft gas leaks.
FDA root cause: Under Investigation by firm
Action: Customers will be sent a product advisory via overnight mail.
Quantity in commerce: 740 units
Distribution: Nationwide
Product codes and lots: UPN: FPRPR3618 UDIs: 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089, 7290104831089 Batch Numbers: U1214, U1215, U1112, U1113, U0958, U0959, U0861, U0862, U0765, U0766, U0729, U0730, U0645, U0643, U0644, U0642, U0426, U0425, U0408, U0160, U0161, T0278, T0275, T0143, T0142, T0134, T0135, A7082, A7032, A7033, A6677, A6678, A2030, A2029, A1775, A1774, A1658, A1544, A1545, A1526, A1188, A1189

Enforcement reports

One row per recalled product line

FDA enforcement reports joined to recall event Z-0659-2021
Recall number	Class	Status	Voluntary or mandated	Report date	Classified
Z-0657-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0658-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0659-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0660-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0661-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0662-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0663-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0664-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0665-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0666-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0667-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0668-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0669-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0670-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0671-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0672-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0673-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0674-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0675-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0676-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0677-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0678-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0679-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0680-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0681-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0682-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0683-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0684-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0685-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0686-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0687-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0688-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0689-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0690-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0691-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0692-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22
Z-0693-2021	Class II	Completed	Voluntary: Firm initiated	2020-12-30	2020-12-22

Product code GEI

K162599Class IIIcePearl 2.1 CX L, IceForce 2.1 CX LGalil Medical , Ltd. / cleared 2016-10-11

MDM coverage of this record lists here, newest first.

About this record

Sourced from the FDA device recall database and the FDA enforcement reports, both ingested from openFDA. The recall record supplies the product, the reason and the product code; the enforcement report supplies the classification. The two datasets are exported by FDA on different days, and the date above is the older of the two, so nothing on this page is newer than it says.

MDM adds the root cause tag, derived from FDA’s own root cause text, and the cross-links to the product code, the clearances named on the record and MDM coverage. Where a recall has not been joined to an enforcement report, no classification is shown.

Data as of 2026-10-07, the FDA export date for this dataset. Page last changed 2026-09-05. View this recall on fda.gov (opens on fda.gov)